Breast Most cancers Canada is launching a 1-million-Canadian-dollar ($730,695 U.S.) fellowship to broaden breast most cancers analysis funding.
One of many grant recipient researchers is Ives Levesque, PhD, of McGill College in Montréal, Québec. He’ll discover the validation of FxMammo, an AI assistant for breast most cancers screening, within the Canadian inhabitants.
The fellowships are funded by AstraZeneca Canada and Breast Most cancers Canada’s annual Precision Oncology Analysis grants.
